Smart Label for medical adherence

As part of DOSEA project, Neutroplast, in partnership with CeNTI, is developing a thin and flexible SmartLabel, that can be attached to medical packages and provide alerts to the users that is time to take the medication. This will lead to higher adherence to the medication, increasing the treatment efficiency, and reducing the wastes associated with the non-adhesion to treatments. The SmartTag is autonomous, reusable and fully configurable, as for the duration of the treatment and intervals at which the medication should be taken. The SmartTag is then a highly attractive product at the pharmaceutical and hospital level, not only for clinical trial cases but also for private users.